Liver cancer: SALL4 - A cancer marker and target

Nature Reviews Clinical Oncology

Volumn 10, Issue 8, 2013, Pages 426-

  Jones, Bryony ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; HISTONE DEACETYLASE INHIBITOR; PEPTIDE DERIVATIVE; PROTEIN SALL4; SCATTER FACTOR RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

DRUG TARGETING; GENE SILENCING; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA INTERFERENCE;

EID: 84881477248     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.112     Document Type: Note

References (1)

1. Yong, K. J. et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N. Engl. J. Med. 368, 2266-2276 (2013)